Trial of Vision Therapy for Intermittent Exotropia
Start Date
10/1/2021
Completion Date
12/1/2025
Summary
The main objective of this randomized trial comparing vision therapy to observation is to determine the short-term effectiveness of vision therapy on distance intermittent exotropia control. The results will help determine whether to proceed to a full-scale, long-term randomized trial.
Detailed Description
Vision therapy (VT) is a commonly prescribed treatment for children with intermittent exotropia (IXT). The effectiveness of VT as a treatment modality for children with IXT is unknown because previous studies have largely limited observational or retrospective case series without comparison groups. The objective of this multi-centered pilot randomized trial of VT for IXT compared to observation is to 1) determine the short-term effectiveness of VT on distance intermittent exotropia and 2) determine the feasibility of recruitment and retention of children aged 8 to 16 years old with IXT to participate in a randomized trial of 20 weeks of in-office VT. The results of this trial will provide the needed information to plan and conduct a large-scale randomized trial to determine short-term and long-term effectiveness of VT for IXT in children, with the full-scale randomized trial helping to fill in the gaps in scientific knowledge concerning VT as a treatment for IXT.
Eligibility Criteria
Age Range: 8 years to 16 years
Interventions
Vision Therapy
Conditions
Locations
University of Alabama in Birmingham
Birmingham, Alabama 35294
United States
Southern California College of Optometry at Marshall B. Ketchum University
Fullerton, California 92831
United States
Stanford University
Stanford, California 94305
United States
Ohio State University
Columbus, Ohio 43210
United States
Salus University
Philadelphia, Pennsylvania 19141
United States
Southern College of Optometry
Memphis, Tennessee 38104
United States